Shopping Cart
- Remove All
Your shopping cart is currently empty
Lefradafiban(BIBU-104) is an oral platelet glycoprotein IIb/IIIa receptor antagonist for the study of angina pectoris and acute coronary syndromes.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $205 | In Stock | |
| 5 mg | $497 | In Stock | |
| 10 mg | $690 | In Stock | |
| 25 mg | $1,000 | In Stock |
| Description | Lefradafiban(BIBU-104) is an oral platelet glycoprotein IIb/IIIa receptor antagonist for the study of angina pectoris and acute coronary syndromes. |
| In vivo | Lefradafiban (30, 45, and 60 mg; oral; three times daily for 48 hours; patients with stable angina undergoing angioplasty) is an effective oral glycoprotein IIb/IIIa receptor blocker.[1] |
| Synonyms | BIBU-104, BIBU104, BIBU 104 |
| Molecular Weight | 439.46 |
| Formula | C23H25N3O6 |
| Cas No. | 149503-79-7 |
| Smiles | C(NC(OC)=O)(=N)C1=CC=C(C=C1)C2=CC=C(OC[C@@H]3C[C@@H](CC(OC)=O)C(=O)N3)C=C2 |
| Relative Density. | 1.32g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (102.4 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.